IP Verse

Preservative Free Bimatoprost And Timolol Solutions

PatentPatent Analysis

EP3431074

ALLERGAN
Application Number
EP18182158A
Filing Date
Jul 28, 2011
Status
Granted And Under Opposition
Dec 17, 2021
Grant Date
Jan 19, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2442821B2
EP3509559B8
EP2877138B1

Bibliography

The patent EP3431074B1 was granted to Allergan on Jan 19, 2022 following the initial filing on Jul 28, 2011 under the application number EP18182158A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKOct 19, 2022ADMISSIBLE
MAIWALDOct 19, 2022ADMISSIBLE
SIFIOct 19, 2022WITHDRAWN
BAUSCH LOMB IRELANDOct 18, 2022ADMISSIBLE
STADA ARZNEIMITTELOct 17, 2022ADMISSIBLE
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIGOct 11, 2022WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents